Cramer DV - Search Results

1

The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat.

Cosenza CA, Cramer DV, Eiras-Hreha G, Cajulis E, Wang HK, Makowka L. Cosenza CA, et al. Among authors: cramer dv. Transplantation. 1993 Sep;56(3):667-72. doi: 10.1097/00007890-199309000-00032. Transplantation. 1993. PMID: 8212165

2

Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.

Shirwan H, Leamer M, Wang HK, Makowka L, Cramer DV. Shirwan H, et al. Among authors: cramer dv. Transplantation. 1995 Feb 15;59(3):401-10. Transplantation. 1995. PMID: 7871571

3

The pathogenesis of xenograft rejection.

Makowka L, Cramer DV. Makowka L, et al. Among authors: cramer dv. Clin Transplant. 1994 Apr;8(2 Pt 2):145-54. Clin Transplant. 1994. PMID: 8019030 Review.

4

Distribution of xenogeneic target antigens detected by a monoclonal antibody capable of inducing hyperacute rejection of hamster cardiac xenografts in rats.

Wu GD, Cramer DV, Kearns M, Eiras-Hreha G, Makowka L. Wu GD, et al. Among authors: cramer dv. Transplant Proc. 1994 Jun;26(3):1382-3. Transplant Proc. 1994. PMID: 8029949 No abstract available.

5

Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.

Cosenza CA, Cramer DV, Tuso PJ, Chapman FA, Wang HK, Makowka L. Cosenza CA, et al. Among authors: cramer dv. J Heart Lung Transplant. 1994 May-Jun;13(3):489-97. J Heart Lung Transplant. 1994. PMID: 8061026

6

Evidence for inbreeding, MHC haplotype matching, and prolonged kidney graft survival in Yucatan miniature swine.

Eiras-Hreha G, Hough K, Cramer DV, Hill D, Cosenza C, Ulker N, Chapman F, Makowka L. Eiras-Hreha G, et al. Among authors: cramer dv. Transplantation. 1993 Jan;55(1):224-7. Transplantation. 1993. PMID: 8093566 No abstract available.

7

The use of brequinar sodium for transplantation.

Cramer DV, Chapman FA, Makowka L. Cramer DV, et al. Ann N Y Acad Sci. 1993 Nov 30;696:216-26. doi: 10.1111/j.1749-6632.1993.tb17154.x. Ann N Y Acad Sci. 1993. PMID: 8109829 Review. No abstract available.

8

The development of Brequinar as an immunosuppressive drug for transplantation.

Makowka L, Sher LS, Cramer DV. Makowka L, et al. Among authors: cramer dv. Immunol Rev. 1993 Dec;136:51-70. doi: 10.1111/j.1600-065x.1993.tb00654.x. Immunol Rev. 1993. PMID: 8132203 Review.

9

Prevention of orthotopic liver allograft rejection in rats with a short-term brequinar sodium therapy. Analysis of intragraft cytokine gene expression.

Shirwan H, Cosenza CA, Wang HK, Wu GD, Makowka L, Cramer DV. Shirwan H, et al. Among authors: cramer dv. Transplantation. 1994 Apr 15;57(7):1072-80. Transplantation. 1994. PMID: 8165706

10

The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.

Yasunaga C, Cramer DV, Chapman FA, Wang HK, Barnett M, Wu GD, Makowka L. Yasunaga C, et al. Among authors: cramer dv. Transplantation. 1993 Oct;56(4):898-904. doi: 10.1097/00007890-199310000-00024. Transplantation. 1993. PMID: 8212214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters